Both in Pharmaceuticals
Tango Therapeutics vs Acadia Pharmaceuticals
Over the past year TNGX returned +195.8% and ACAD returned −12.0%; their daily moves had a correlation of 0.19.
TNGX +195.8% ACAD −12.0%Growth of $1, one year, split-adjusted
| Metric | TNGX | ACAD |
|---|---|---|
| Price | $22.98 | $20.24 |
| Market cap | $3.87B | $3.49B |
| Today | +0.39% | +0.32% |
| 1 month | −5.9% | +0.1% |
| 6 months | +4.2% | −8.9% |
| Year to date | +159.4% | −24.2% |
| 1 year | +195.8% | −12.0% |
| Revenue growth (YoY) | −100.0% | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.2× |
| Price / sales | 72.0× | 3.1× |
| Net cash | $1.01B | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 72.7% | 45.9% |
| Short % of float | 31.9% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).